Social Pulse: Astellas Pharma Inc (4503.T)
4503.T on Tokyo Stock Exchange
5,700JPY
20 May 2013
5,700JPY
20 May 2013
Price Change (% chg)
¥-130 (-2.23%)
¥-130 (-2.23%)
Prev Close
¥5,750
¥5,750
Open
¥5,820
¥5,820
Day's High
¥5,830
¥5,830
Day's Low
¥5,690
¥5,690
Volume
2,654,900
2,654,900
Avg. Vol
2,020,716
2,020,716
52-wk High
¥6,010
¥6,010
52-wk Low
¥3,020
¥3,020
Press Releases
- Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
- Astellas Submits Supplemental New Drug Application to FDA for Tarceva® as a First-Line Therapy in Genetically Distinct Form of Non-Small Cell Lung Cancer
- Astellas and Ambit Announce Data Presentations Highlighting Quizartinib at the American Society of Hematology 54th Annual Meeting
- MYRBETRIQ™ (mirabegron), Overactive Bladder Treatment from Astellas, Now Available Through U.S. Pharmacies
- Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
